May 28 — Digital Angel Corp., an advanced technology company in the field of rapid and accurate identification, location tracking and condition monitoring of high-value assets, and VeriChip Corp., a provider of RFID systems for healthcare and patient-related needs, have announced they have established a joint committee to design and develop a working, implantable glucose microchip to determine glucose levels in the bodies of animals and humans. The novel device would negate the need for diabetics to draw blood in order to monitor their individual blood glucose levels.
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now